Edge Pharma, LLC recalls Methotrexate, USP, Sterile Solution for Injection (PF), 125 mg/5mL (2mg/mL), 5 mL per syringe, Edge Pharma, LLC, 856 Her
Recalled February 2, 2022 · FDA recall D-0406-2022 · Edge Pharma
Hazard
Lack of Assurance of Sterility · FDA Class II
Units
457 syringes
Sold at
nationwide
Description
Lack of Assurance of Sterility
Product
Methotrexate, USP, Sterile Solution for Injection (PF), 125 mg/5mL (2mg/mL), 5 mL per syringe, Edge Pharma, LLC, 856 Hercules Dr, Colchester, VT 05446, NDC 05446-1505-05
Manufacturer(s)
Edge Pharma, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →